Literature DB >> 23925487

Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis.

Ilambarthi Lokamani1, Mee-Lee Looi, Siti Aishah Md Ali, Ahmad Zailani Hatta Mohd Dali, Muhammad Azrif Ahmad Annuar, Rahman Jamal.   

Abstract

This study aimed to identify candidate proteins which may serve as potential biological markers for cervical cancer using 2D-DIGE. Serum samples of controls, patients with cervical intraepithelial neoplasia grade 3 (CIN 3), squamous cell carcinoma of early (SCC I and II) and late (SCC III and IV) stage were subjected to 2D-DIGE. Differentially expressed spots were identified by tandem mass spectrometry. Validation of candidate proteins in serum and tissue samples were then performed by ELISA and immunohistochemistry (IHC) analysis respectively. A total of 20 differentially expressed proteins were identified. These proteins were found to play key roles in the apoptosis pathway, complement system, various types of transportation such as hormones, fatty acids, lipid, vitamin E and drug transportation, coagulation cascade, regulation of iron and immunologic response. Based on their functional relevancy to the progression of various cancers, 4 proteins namely the complement factor H, CD5-like antigen, gelsolin and ceruloplasmin were chosen for further validation using ELISA. Biological network analysis showed that ceruloplasmin and gelsolin are closely interacted with the oncogene NF-κb. These two proteins were further validated using the IHC. Gelsolin and ceruloplasmin may serve as potential predictive biomarkers for the progression of high grade lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925487     DOI: 10.1007/s12253-013-9670-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  59 in total

Review 1.  Cancer and the complement cascade.

Authors:  Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Steven A Mills; Andrew T Parsa
Journal:  Mol Cancer Res       Date:  2010-09-24       Impact factor: 5.852

Review 2.  Role of iron in estrogen-induced cancer.

Authors:  J G Liehr; J S Jones
Journal:  Curr Med Chem       Date:  2001-06       Impact factor: 4.530

3.  Serum levels of some acute phase proteins in kidney and urinary tract urothelial cancers.

Authors:  M Pejovic; V Djordjevic; I Ignjatovic; T Stamenic; V Stefanovic
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect.

Authors:  H Fujita; F Okada; J Hamada ; M Hosokawa; T Moriuchi; R C Koya; N Kuzumaki
Journal:  Int J Cancer       Date:  2001-09       Impact factor: 7.396

Review 5.  The transcription factor nuclear factor-kappa B and cancer.

Authors:  R O Escárcega; S Fuentes-Alexandro; M García-Carrasco; A Gatica; A Zamora
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-03       Impact factor: 4.126

6.  Complement factor H or a related protein is a marker for transitional cell cancer of the bladder.

Authors:  R Kinders; T Jones; R Root; C Bruce; H Murchison; M Corey; L Williams; D Enfield; G M Hass
Journal:  Clin Cancer Res       Date:  1998-10       Impact factor: 12.531

7.  Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin.

Authors:  H L Yin; D J Kwiatkowski; J E Mole; F S Cole
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

8.  Protein expression profile characteristic to hepatocellular carcinoma revealed by 2D-DIGE with supervised learning.

Authors:  Reiji Teramoto; Hirotaka Minagawa; Masao Honda; Kenji Miyazaki; Yo Tabuse; Ken'ichi Kamijo; Teruyuki Ueda; Shuichi Kaneko
Journal:  Biochim Biophys Acta       Date:  2008-03-05

9.  Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors.

Authors:  Saeid R Doustjalali; Rohana Yusof; Cheng-Har Yip; Lai-Meng Looi; Bhanumathy Pillay; Onn H Hashim
Journal:  Electrophoresis       Date:  2004-07       Impact factor: 3.535

10.  2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers.

Authors:  Ge Zhou; Hongmei Li; Dianne DeCamp; She Chen; Hongjun Shu; Yi Gong; Michael Flaig; John W Gillespie; Nan Hu; Philip R Taylor; Michael R Emmert-Buck; Lance A Liotta; Emanuel F Petricoin; Yingming Zhao
Journal:  Mol Cell Proteomics       Date:  2002-02       Impact factor: 5.911

View more
  10 in total

1.  Urinary biomarkers for the early diagnosis of retinopathy and nephropathy in type 1 diabetes mellitus: a "steady stream" of information using proteomics.

Authors:  Emily K Sims; Carmella Evans-Molina
Journal:  Transl Res       Date:  2013-11-28       Impact factor: 7.012

2.  [LC-MS/MS-based screening of new protein biomarkers for cervical precancerous lesions and cervical cancer].

Authors:  Feng Qiu; Fu Chen; Dongdong Liu; Jianhua Xu; Jingling He; Jujiao Xiao; Longbin Cao; Xianzhang Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

3.  Gelsolin suppresses gastric cancer metastasis through inhibition of PKR-p38 signaling.

Authors:  Xiangliang Yuan; Weiwei Wang; Junhua Li; Peiming Zheng; Ping Dong; Lei Chen; Yunlan Zhou; Guohua Xie; Dakang Xu; Yingbin Liu; Lisong Shen
Journal:  Oncotarget       Date:  2016-08-16

4.  IPA Analysis of Cervicovaginal Fluid from Precancerous Women Points to the Presence of Biomarkers for the Precancerous State of Cervical Carcinoma.

Authors:  Xaveer Van Ostade; Martin Dom; Geert Van Raemdonck
Journal:  Proteomes       Date:  2014-08-13

5.  Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.

Authors:  Eisuke Miyauchi; Takuya Furuta; Sumio Ohtsuki; Masanori Tachikawa; Yasuo Uchida; Hemragul Sabit; Wataru Obuchi; Tomoko Baba; Michitoshi Watanabe; Tetsuya Terasaki; Mitsutoshi Nakada
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

6.  Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients.

Authors:  Zhuoyu Chen; Kaifei Li; Xiaofeng Yin; Haixia Li; Yao Li; Qiong Zhang; Haifang Wang; Yurong Qiu
Journal:  J Cancer       Date:  2019-01-30       Impact factor: 4.207

7.  Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.

Authors:  Fei Chen; Bihui Han; Yanxiu Meng; Yu Han; Bing Liu; Bo Zhang; Yanzhong Chang; Pengxiu Cao; Yumei Fan; Ke Tan
Journal:  Aging (Albany NY)       Date:  2021-08-19       Impact factor: 5.682

8.  Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.

Authors:  Lee Admoni-Elisha; Itay Nakdimon; Anna Shteinfer; Tal Prezma; Tasleem Arif; Nir Arbel; Anna Melkov; Ori Zelichov; Itai Levi; Varda Shoshan-Barmatz
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

9.  Label-free quantitative proteomic analysis of gingival crevicular fluid to identify potential early markers for root resorption.

Authors:  Farah Amirah Mohd Nasri; Shahrul Hisham Zainal Ariffin; Saiful Anuar Karsani; Rohaya Megat Abdul Wahab
Journal:  BMC Oral Health       Date:  2020-09-11       Impact factor: 2.757

Review 10.  Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target.

Authors:  Ewelina Piktel; Ilya Levental; Bonita Durnaś; Paul A Janmey; Robert Bucki
Journal:  Int J Mol Sci       Date:  2018-08-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.